BNR vs. OVB, NFX, OCTP, PYC, IDHC, N4P, DEMG, TRLS, HELD, and GDR
Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Ovoca Bio (OVB), Nuformix (NFX), Oxford Cannabinoid Technologies (OCTP), Physiomics (PYC), Integrated Diagnostics (IDHC), N4 Pharma (N4P), Deltex Medical Group (DEMG), Trellus Health (TRLS), Hellenic Dynamics (HELD), and genedrive (GDR). These companies are all part of the "medical" sector.
Burning Rock Biotech (LON:BNR) and Ovoca Bio (LON:OVB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, community ranking, dividends, institutional ownership, risk and earnings.
Burning Rock Biotech received 48 more outperform votes than Ovoca Bio when rated by MarketBeat users. However, 70.83% of users gave Ovoca Bio an outperform vote while only 69.89% of users gave Burning Rock Biotech an outperform vote.
Burning Rock Biotech's return on equity of 0.00% beat Ovoca Bio's return on equity.
In the previous week, Burning Rock Biotech had 1 more articles in the media than Ovoca Bio. MarketBeat recorded 1 mentions for Burning Rock Biotech and 0 mentions for Ovoca Bio. Burning Rock Biotech's average media sentiment score of 0.00 equaled Ovoca Bio'saverage media sentiment score.
Summary
Burning Rock Biotech beats Ovoca Bio on 4 of the 5 factors compared between the two stocks.
Get Burning Rock Biotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Burning Rock Biotech Competitors List
Related Companies and Tools
